Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Us Breaking News Us Fda Approves Emergent S Smallpox Vaccine For People At High Risk Of Mpox is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
US Government signs $56m smallpox/mpox vaccine order despite political disarray
"US Government signs $56m smallpox/mpox vaccine order despite political disarray" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. Read More
Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance ...
Emergent BioSolutions Inc. (NYSE: EBS) today announced that a contract modification has been executed in the amount of $56 million to supply ACAM2000 ®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) to ... Read More
US FDA narrows under-65 COVID vaccine eligibility; maintains full access for older Americans
The U.S. Food and Drug Administration cleared updated COVID-19 vaccines for everyone over age 65 but narrowed its approval for younger people to those with health risks, the companies said on ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus